WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 15'2301 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 21'9111 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 17'620  17'465  17'308  17'151  16'992  15'454  13'214  11'192 
Births 245  246  246  246  246  258  305  257 
Surviving infants 244  244  244  244  244  255  301  248 
Pop. less than 5 years 1'224  1'225  1'226  1'224  1'227  1'333  1'466  1'182 
Pop. less than 15 years 3'715  3'736  3'763  3'797  3'844  4'294  3'959  3'701 
Female 15-49 years 4'594  4'593  4'586  4'571  4'549  4'117  3'561  2'913 

Number of reported case

(Click for retrospective incidence data for Chile)
Diphtheria 36  253 
Japanese encephalitis
Measles 1'958  3'844 
Mumps 821  876  950  891  825  2'352 
Pertussis 1'964  5'762  2'582  794  692  3'554  59  2'795 
Polio*
Rubella 743 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 10  12  10  22  31 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Chile)
Vaccine year result method % card seen                                                
BCG          98  92  91  96  95  93  94  96 
DTP1          92  90  94  93  94  98 
DTP3          91  90  94  92  94  91  95  93 
HepB_BD         
HepB3          90  90  94  92  94 
Hib3          90  90  94  92  94  91 
JapEnc         
MCV          90  90  91  93  93  97  97  94 
MCV2          78  74  77  84  89 
PCV1          92  90  83 
PCV3          79  82  55 
Pol3          90  90  93  92  94  91  95  93 
Rota1         
Rota_last         
Rubella1          90  90  91  93  93 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Chile)
BCG 98  92  91  95  95  93  94  96 
DTP1 92  90  98  93  94  98  98  97 
DTP3 91  90  94  92  94  91  95  93 
HepB3 90  90  94  92  94 
HepB_BD
Hib3 90  90  94  92  94  91 
MCV 90  90  91  93  93  97  97  94 
MCV2 78  74  77  84  89 
PnC3 79  82  54 
Pol3 90  90  93  92  94  91  95  93 
Rota_last

Number of districts in the country 345  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89%
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
HPV From July 2014
HepA 18 months; No From January 2014
Influenza 6-23 months; > 65 years; Yes and risk groups
MMR 1, 6 years; Yes
MenACWY 9 months; 1 year; Yes From January 2014, 1 dose at 1 year
OPV 2, 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps 65 years; Yes
Tdap 6, 13 years;

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  No  No  No  Yes 
What years does the MYP cover? number     2'011        Anual 
Nº of districts with microplans that include activities to raise immunization coverage number             28 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 345  346  346    340  346  345 
Nº districts with DTP3 coverage >=80% number 170  238  293  293  299  65 
% of districts with DTP3 coverage >=80% From 0 to 100% 49  69    86  86  19 
Nº districts with measles (MCV1) coverage >=95% number   84  105  163  163  190   
% of districts with MCV1 coverage >=95% From 0 to 100%   24  30    48  55   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No           
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes    No  No  No  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100    100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.